We are live on ! Find out more
T. Rowe Price Associates

T. Rowe Price Associates Portfolio holdings

AUM $865B
1-Year Est. Return 30.76%
 

T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.

This Fund
S&P 500
This Quarter Est. Return
+1.52%
1 Year Est. Return
+30.76%
3 Year Est. Return
+117.39%
5 Year Est. Return
+143.85%
10 Year Est. Return
+1,089.89%
AUM
$486B
AUM Growth
+$2.12B
Cap. Flow
+$867M
Cap. Flow %
0.18%
Top 10 Hldgs %
13.96%
Holding
2,615
New
76
Increased
1,051
Reduced
777
Closed
79

Top Buys

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$3.76B
2
CI icon
Cigna
CI
+$1.44B
3
BMY icon
Bristol-Myers Squibb
BMY
+$1.26B
4
OXY icon
Occidental Petroleum
OXY
+$763M
5
DHR icon
Danaher
DHR
+$762M

Sector Composition

Rank Sector Weight
1 Healthcare 22.87%
2 Financials 13.64%
3 Consumer Discretionary 13.54%
4 Industrials 10.67%
5 Technology 10.39%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
LKFN icon
2051
Lakeland Financial Corp
LKFN
$1.55B
$425K ﹤0.01%
14,700
+1,800
+14% +$48.8K
AX icon
2052
Axos Financial
AX
$5.68B
$423K ﹤0.01%
16,000
CHCO icon
2053
City Holding Co
CHCO
$2.07B
$421K ﹤0.01%
8,550
EVR icon
2054
Evercore
EVR
$11.5B
$421K ﹤0.01%
7,800
-42,777
-85% -$2.18M
SMP icon
2055
Standard Motor Products
SMP
$877M
$420K ﹤0.01%
11,950
VSH icon
2056
Vishay Intertechnology
VSH
$5.15B
$420K ﹤0.01%
35,998
CYNO
2057
DELISTED
Cynosure, Inc. Class A
CYNO
$419K ﹤0.01%
10,857
CNOB icon
2058
Center Bancorp
CNOB
$1.81B
$417K ﹤0.01%
19,383
AF
2059
DELISTED
Astoria Financial Corporation
AF
$417K ﹤0.01%
30,221
TAL
2060
DELISTED
TAL INTERNATIONAL GROUP, INC.
TAL
$417K ﹤0.01%
13,200
QTS
2061
DELISTED
QTS REALTY TRUST, INC.
QTS
$416K ﹤0.01%
11,400
+1,500
+15% +$55.5K
TRI icon
2062
Thomson Reuters
TRI
$44.5B
$415K ﹤0.01%
9,392
+1,809
+24% +$84.7K
UNF icon
2063
Unifirst Corp
UNF
$5.24B
$414K ﹤0.01%
3,700
RDNT icon
2064
RadNet
RDNT
$6.06B
$413K ﹤0.01%
61,700
+6,500
+12% +$49.8K
TLK icon
2065
Telkom Indonesia
TLK
$14.4B
$410K ﹤0.01%
18,914
+3,540
+23% +$76.4K
GTI
2066
DELISTED
GRAFTECH INTERNATIONAL LTD
GTI
$409K ﹤0.01%
82,450
SYKE
2067
DELISTED
SYKES Enterprises Inc
SYKE
$408K ﹤0.01%
16,840
ECPG icon
2068
Encore Capital Group
ECPG
$2.07B
$406K ﹤0.01%
9,500
NTGR icon
2069
NETGEAR
NTGR
$658M
$402K ﹤0.01%
13,400
+3,900
+41% +$122K
PHLT
2070
DELISTED
Performant Healthcare Inc
PHLT
$400K ﹤0.01%
123,500
OUTR
2071
DELISTED
OUTERWALL INC
OUTR
$400K ﹤0.01%
5,250
EDR
2072
DELISTED
Education Realty Trust Inc
EDR
$398K ﹤0.01%
12,703
+330
+3% +$11K
BSFT
2073
DELISTED
BroadSoft, Inc.
BSFT
$398K ﹤0.01%
11,500
BRKL
2074
DELISTED
Brookline Bancorp
BRKL
$395K ﹤0.01%
34,999
ONB icon
2075
Old National Bancorp
ONB
$10.4B
$395K ﹤0.01%
27,343

Similar funds

T. Rowe Price Associates's Q2 2015 Portfolio in Review

As of Q2 2015, T. Rowe Price Associates held 2,615 positions worth $486B, up 0.44% from $484B the previous quarter. Its ten largest holdings account for 14% of the portfolio.

T. Rowe Price Associates's Q2 2015 filing shows 76 new, 1,051 increased, 777 reduced and 79 closed positions. Its largest new stake was Allergan plc: 548,825 shares worth $570M. The largest sale was PHARMACYCLICS INC, an estimated $2.46B.

By sector, the portfolio is most concentrated in Healthcare at 23% of assets, up from 21% a quarter earlier, followed by Financials and Consumer Discretionary.

  • T. Rowe Price Associates's largest Q2 2015 buy was Allergan plc: 548,825 shares worth $570M.
  • T. Rowe Price Associates added most to Microsoft in Q2 2015, an estimated $3.76B increase.
  • T. Rowe Price Associates's biggest Q2 2015 reduction was Wynn Resorts, cutting an estimated $1.11B.
  • T. Rowe Price Associates fully exited PHARMACYCLICS INC in Q2 2015, selling an estimated $2.46B.
  • T. Rowe Price Associates's ten largest holdings make up 14% of its $486B portfolio in Q2 2015.
  • T. Rowe Price Associates opened 76 new positions and closed 79 in Q2 2015.
  • T. Rowe Price Associates's portfolio value rose 0.44% quarter-over-quarter to $486B.

Based on T. Rowe Price Associates's 13F filing for Q2 2015, filed 14 Aug 2015.